PETS vs FRPT

For growth investors, Freshpet, Inc.

(FRPT) is the stronger pick with 13. 0% revenue growth year-over-year, versus -17. 2% for PetMed Express, Inc. (PETS). Freshpet, Inc. (FRPT) offers the better valuation at 20. 8x trailing P/E (40. 4x forward), making it the more compelling value choice. Analysts rate Freshpet, Inc. (FRPT) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Freshpet, Inc.

(FRPT) delivered a total return of -68. 1%, compared to -82. 6% for PetMed Express, Inc. (PETS). Over 10 years, the gap is even starker: FRPT returned +515. 1% versus PETS's -45. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Freshpet, Inc.

(FRPT) is the lower-risk stock at 0. 91β versus PetMed Express, Inc. 's 1. 25β — meaning PETS is approximately 38% more volatile than FRPT relative to the S&P 500. On balance sheet safety, PetMed Express, Inc. (PETS) carries a lower debt/equity ratio of 1% versus 46% for Freshpet, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Freshpet, Inc.

(FRPT) is pulling ahead at 13. 0% versus -17. 2% for PetMed Express, Inc. (PETS). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to 18. 9% for PetMed Express, Inc.. Over a 3-year CAGR, FRPT leads at 22. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Freshpet, Inc.

(FRPT) is the more profitable company, earning 12. 6% net margin versus -2. 8% for PetMed Express, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FRPT leads at 8. 6% versus -0. 7% for PETS. At the gross margin level — before operating expenses — FRPT leads at 38. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, PETS (0.

4% yield) pays a dividend. FRPT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Freshpet, Inc.

(FRPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91), +515. 1% 10Y return). Both have compounded well over 10 years (FRPT: +515. 1%, PETS: -45. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PETS (Healthcare) and FRPT (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.